ABI Mass Spec Revs Climb 14 Percent for Q2; Overall Revs Up 10 Percent 
 
Mass spectrometry revenues rose 14 percent during its fiscal second quarter helping drive up overall revenues at Applied Biosystems by 10 percent, the company said this week.
 
For the period ended Dec. 31, revenues generated from mass spec sales totaled $135.9 million, or 26 percent of ABI’s total revenues of $530 million.
 

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Five researchers are to share this year's Albany Medical Center Prize for their work on the CRISPR/Cas9 gene-editing tool, the AP reports.

Stat News reports on how white supremacists cope with surprising genetic ancestry testing results.

In Genome Research this week: sex-biased gene expression evolution in malaria mosquitos, method to find ancient selective sweeps, and more.

Iceland has nearly eliminated Down syndrome from its population, CBS News reports.